9 Aug 2025
Comparative analysis of serum SCC antigen levels in inverted sinonasal papilloma and nasal polyps: a diagnostic meta-analysisPublisher siteEuropean Archives of Oto-Rhino-Laryngology, Head and Neck Surgical Oncology
UniversitiesHesham A. M. Gomaa
Active, last published 2026
Hesham A. M.
Gomaa
Scholar“Research profile drawn from open scholarly records.”
Jouf University
Claim Your Profile4
H-index
46
Citations
Hesham has not officially claimed their profile. If you are Hesham, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Hesham A. M. Gomaa will appear here once their profile is updated.
02 · Reach
Publication output and reach
Hesham's work has been cited 46 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchJouf UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
8 works6 May 2025Open access10cites
Design, synthesis, and biological investigation of new thiazole-based derivatives as multi-targeted inhibitors endowed with antiproliferative, antioxidant, and antibacterial propertiesPublisher siteFrontiers in Chemistry, Synthesis and biological activity
29 Jul 20245cites
Microwave-assisted synthesis of 2,5-dioxo-pyrano[3,2-c]quinoline-3-carboxylates and their investigation as antiproliferative agents targeting EGFR and/or BRAFV600EPublisher siteChemical Papers, Multicomponent Synthesis of Heterocycles
21 Jun 2024Open access14cites
Design, synthesis, and antiproliferative activity of new indole/1,2,4‐triazole/chalcone hybrids as EGFR and/or c‐MET inhibitorsPublisher siteArchiv der Pharmazie, Synthesis and biological activity
7 Jun 2024Open access11cites
Discovery of new Schiff bases of the disalicylic acid scaffold as DNA gyrase and topoisomerase IV inhibitors endowed with antibacterial propertiesPublisher siteFrontiers in Chemistry, Cancer therapeutics and mechanisms
5 Sept 2023Open access1cites
Corrigendum: Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisibPublisher siteFrontiers in Pharmacology, Drug-Induced Hepatotoxicity and Protection
7 Aug 2023Open access2cites
Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisibPublisher siteFrontiers in Pharmacology, Drug-Induced Hepatotoxicity and Protection
29 May 20233cites
Emerging roles of tyrosine kinases in hepatic inflammatory diseases and therapeutic opportunitiesPublisher siteInternational Immunopharmacology, Liver Disease Diagnosis and Treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Hesham?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you